New film debuts shortly after the success of the Oscar-Nominated film, Silver Linings Playbook
NEWARK, NJ –The public is invited to attend a special screening of the animated film Escape From Planet Earth on Sunday, February 10, at the New Jersey Performing Arts Center (NJPAC), One Center Street, Newark. An afternoon party complete with a red carpet, games and surprises for children, will begin at 1pm followed by the movie screening at 3 pm. The event will benefit The Harvey and Georgina Weinstein National Heart Transplant Center at Newark Beth Israel Medical Center (NBIMC).
Click here for information about purchasing tickets to the reception and movie screening. Or, call 973-926-8128.
Click here to view a trailer of The Weinstein Company’s film that will debut in movie theaters nationwide just four days after the Feb. 10th screening at NJPAC. The film features the voices of an all-star cast including: Sarah Jessica Parker, William Shatner, Brendan Fraser, Jessica Alba, George Lopez, Rob Corddry, Jane Lynch and Sofia Vergara.
A partnership formed after Marvin Peart, executive producer of Escape From Planet Earth, his father received a heart transplant at Newark Beth Israel Medical Center. As a result, the special screening will benefit the Harvey and Georgina Weinstein National Heart Transplant Center at NBIMC.
Peart is planning to treat his son’s entire second-grade class to see the movie at NJPAC four days before the animated film is shown in movie theaters nationwide on Valentine’s Day. Peart, a Marlboro resident (Monmouth County), is believed to be the first African-American man to serve as an executive producer of a major animated film.
The Harvey and Georgina Weinstein National Heart Transplant Center, established in 2012, continues Newark Beth Israel Medical Center’s long tradition in the field of heart transplant medicine and expands its ability to provide evaluation, advanced treatment and follow-up care for people across the Northeast. Over 725 heart transplants, 70 lung transplants and 350 ventricular assist device implants have been performed by the team that will continue to be led by Mark J. Zucker, MD, JD, an internationally respected leader in heart transplant medicine.
“It has been my pride and joy to have the ability to bring movies to audiences around the world,” Harvey Weinstein, Co-Chairman of The Weinstein Company, said in November at the New York premiere of the movie Silver Linings Playbook which also benefited the transplant center. “Today we were able to extend the lens further by shedding light on something important to Georgina and me – heart transplantation. Newark Beth Israel Medical Center, as one of the top three heart transplant programs in the country with great outcomes, is that silver lining heart transplant patients need for quality and longevity of life.”
“The partnership with The Weinstein Company, Harvey Weinstein and Marvin Peart is vitally important as we begin a new chapter in transplant surgery,” said John A. Brennan, MD, MPH, President and Chief Executive Officer of Newark Beth Israel Medical Center and Children’s Hospital of New Jersey. “The new Harvey and Georgina National Heart Transplant Center, with the latest technology and services, will help us maintain our ranking as one of the top three heart transplant centers nationwide.”
The transplant team at Newark Beth Israel Medical Center performed 69 heart transplants in 2012, a record high for the hospital. The program ranks as the third largest in the U.S. and has gained recognition for it successful outcomes. In addition to exceptional patient care, The Harvey and Georgina Weinstein National Heart Transplant Center is at the forefront of clinical research and will offer the benefits of the latest generation of ventricular assist devices, a revolutionary donor organ preservation system and stem cell therapy. The immunosuppression protocol developed at Newark Beth Israel allows many heart recipients to maintain their transplanted organ without the traditional steroid medications that are associated with serious and unpleasant side effects. This unique research is improving the medical management and survival rates for transplant recipients worldwide.
According to the Scientific Registry of Transplant Recipients, which maintains the national database of transplant statistics and supports the scientific and clinical evaluation of organ transplantation, both the Heart and Lung Transplant Programs at Newark Beth Israel Medical Center have consistently achieved patient survival rates that meet or exceed national benchmarks. For two consecutive years, the Heart and Lung Transplant Programs were awarded the Bronze Level by the U.S. Department of Health and Human Services’ Donation and Transplant Community of Practice. This award recognizes programs that improve the success of transplantation and increase organ donation and Newark Beth Israel Medical Center was one of only two hospitals in the Northeast to earn this recognition.
Newark Beth Israel Medical Center, (NBIMC), a 673-bed regional care teaching hospital, provides comprehensive health care to its local communities and well beyond. NBIMC has more than 800 physicians, 3,200 employees and 150 volunteers with over 300,000 outpatient visits and 25,000 admissions annually. NBIMC is one of the top three in heart transplants with better than expected outcomes, has the only lung transplant program in New Jersey, and combined with Saint Barnabas Medical Center, both Barnabas Health affiliates, is third in the nation for kidney transplants, by volume. To learn more, visit us on line at www.newarkbeth.com.
Date: February 4, 2013
Contact: Kaylyn Kendall Dines
Public Relations Department